Skip to main content
Dataset · v1.0 · Released 2026-05-19

The Apellica External Review Index.

How often a U.S. state-licensed Independent Review Organization overturns an insurance denial ranges from 17.0% in West Virginia to 80.0% in Connecticut. Most states do not even publish the number. This is the first comprehensive 2026 public-record dataset, with every cell anchored to a verifiable government source.

56
Jurisdictions covered
14
With measured rate
47
State-run programs
9
HHS-administered

Released by Apellica under CC-BY-4.0. Reuse it. Cite it. Improve it. Open an issue or send corrections to editorial@apellica.com.

What this dataset is

A working map of the data the system does not publish.

The Affordable Care Act gave every American with a fully-insured plan the right to ask a state-licensed Independent Review Organization to re-decide a denial after the insurer's own internal appeal process is exhausted. The reviewer is independent. The decision is binding on the insurer.

How often that reviewer sides with the patient is wildly different depending on which state you live in. And in most states, the regulator does not publicly publish the number at all.

This dataset assembles what each state's Department of Insurance, legislative report, or CMS publication says about their external-review program, in one place, with every number anchored to a verifiable public-record URL. Empty cells are deliberately empty when the underlying state has not published the number. We do not extrapolate.

The single largest finding of the exercise is that transparency itself is the lottery. 42 of 56 jurisdictions do not publish discoverable current external-review statistics. The patient who needs the data to decide whether to appeal has no way to get it.

The dataset

External-review reversal rate by jurisdiction.

Sorted by reversal rate (highest first). Click any row to open the source.
JurisdictionYearReversal rateCasesOverturnedSystemRegulator
Connecticut
CT
2024
80.0%
High reversal
n/an/astate-runConnecticut Insurance Department / Office of the Healthcare Advocate
Notes

Healthcare Advocate office reports denials resolved/overturned in patient's favor ~80% of cases. Counts include both formal IRO reversals and pre-decision insurer concessions after advocate involvement. CT total denial rate among largest insurers was 14% in 2024.

California
CA
2024
72.7%
High reversal
n/an/astate-runCalifornia Department of Managed Health Care (DMHC)
Notes

Headline: ~73% of IMR cases end with enrollee receiving requested service (full+partial overturn by IMRO + plan reversals during review). Of cases reaching final IMRO determination, overturn rate of treatment-denial decisions was 12.7% in 2024 (up from 10.2% in 2023). Full open-data trend file: https://data.chhs.ca.gov/dataset/independent-medical-review-imr-determinations-trend

Maryland
MD
2024
66.8%
High reversal
n/an/astate-runMaryland Insurance Administration (MIA)
Notes

MIA reversed or modified the carrier's grievance decision 66.8% of the time in 2024, per MIA's 2024 Health Care Appeals and Grievance Law Report. Down 2.9 pts from prior year. Note: this is MIA's complaint-handling reversal rate, broader than IRO-only external review. Source PDF identified.

North Carolina
NC
2024
54.3%
High reversal
282153state-runNorth Carolina Department of Insurance (Smart NC)
Notes

Smart NC received 282 external review requests through November 2024 and overturned 153 (~53%). Per Smart NC and NBC News reporting (2025). Annual report: https://www.ncleg.gov/Files/Library/agency/doi13339.pdf

Kansas
KS
2024
54.0%
High reversal
n/an/astate-runKansas Insurance Department
Notes

~54% overturn rate cited by NBC News (2025) attributing to Kansas Department of Insurance covering data since 2018. Cumulative period rate; not single-year. Department publishes Independent Medical Review program at: https://insurance.ks.gov/documents/department/publications/independent-medical-review.pdf

Pennsylvania
PA
2025
48.4%
Moderate
1,353655state-runPennsylvania Insurance Department (PID)
Notes

PA Independent External Review Program (launched 2024-01) referred 1353 eligible cases to IROs since inception through 2025; 655 overturned (~48%). First-year (2024) rate was 50.1%. Program is one of newest state-run replacements for HHS-administered process.

Colorado
CO
2024
44.0%
Moderate
n/an/astate-runColorado Division of Insurance (DORA)
Notes

~44% overturn rate cited by Division (per NBC News 2025 coverage attributing to DORA). Statistical report exists but item-level external-review tables not extracted; flag as secondary citation.

Minnesota
MN
2024
43.0%
Moderate
n/an/astate-runMinnesota Department of Commerce
Notes

43% of external reviews resulted in coverage denials being overturned in 2024, per Department of Commerce (cited via KSTP News). Filing fee dropped 2024-08-01 to increase access.

South Carolina
SC
2024
43.0%
Moderate
n/an/astate-runSouth Carolina Department of Insurance
Notes

~43% of cases reversed in 2024 per NBC News attribution to SCDOI. SC DOI does not publish dedicated annual external-review report online; flag as secondary citation.

Massachusetts
MA
2023
40.0%
Moderate
n/an/astate-runMassachusetts Office of Patient Protection (OPP) at Health Policy Commission
Notes

~40% of OPP external reviews resolved in patient's favor per OPP 2023 Annual Report referenced by MA HPC. 2024 report not yet located; flag as most-recent-published is 2023.

Oregon
OR
2025
38.9%
Moderate
278108state-runOregon Division of Financial Regulation (DFR)
Notes

Oregon DFR IRO Case Detail Report (current through 2025-06-30): 352 cases received, 278 completed full review, 108 overturned or partially overturned (39%), 170 upheld. Excel-format quarterly updates.

Washington
WA
2024
25.0%
Low reversal
n/an/astate-runWashington Office of the Insurance Commissioner (OIC)
Notes

~25% overturn rate in 2024 per NBC News attribution to WA OIC. 2024 WA OIC Annual Report identified.

Arizona
AZ
2014
21.0%
Low reversal
n/an/astate-runArizona Department of Insurance and Financial Institutions (DIFI)
Notes

Historic KFF-cited figure (21%). DIFI does not publish a current external-review annual report; flagged as stale.

West Virginia
WV
2024
17.0%
Low reversal
n/an/astate-runWest Virginia Offices of the Insurance Commissioner
Notes

~17% overturn rate over the last 5 years (through 2024) per NBC News attribution to WV OIC. Cumulative period rate; not single-year. Significantly below national average.

Alabama
AL
2024
n/a
HHS-administered
n/an/aHHS-administeredHHS-Administered Federal External Review (MAXIMUS Federal Services)
Notes

Data gap: HHS-administered process; CMS does not publish state-level case totals. Alabama has no state-run external review system.

Alaska
AK
n/a
n/a
No published rate found
n/an/astate-runAlaska Division of Insurance
Notes

Data gap: Division publishes annual reports but does not publicly itemize IRO external-review case totals or overturn rates.

American Samoa
AS
n/a
n/a
HHS-administered
n/an/aHHS-administeredHHS-Administered Federal External Review (MAXIMUS Federal Services)
Notes

U.S. territory using HHS-administered federal process. CMS does not publish jurisdiction-level case totals.

Arkansas
AR
n/a
n/a
No published rate found
n/an/astate-runArkansas Insurance Department
Notes

Data gap: Arkansas Insurance Department does not publish a public external-review annual statistics report.

Delaware
DE
n/a
n/a
No published rate found
n/an/astate-runDelaware Department of Insurance
Notes

Data gap: Delaware's Independent Health Care Appeals Program (IHCAP) does not publicly post external-review tabular statistics.

District of Columbia
DC
n/a
n/a
No published rate found
n/an/astate-runDC Department of Insurance Securities and Banking (DISB)
Notes

Data gap: DISB does not publish a dedicated external-review annual statistics document.

Florida
FL
2024
n/a
HHS-administered
n/an/aHHS-administeredHHS-Administered Federal External Review (MAXIMUS Federal Services)
Notes

Florida participates in HHS-administered federal external review (no compliant state-run process for federally regulated plans). FL OIR does not publish corresponding overturn statistics. Data gap on state-level totals.

Georgia
GA
2024
n/a
HHS-administered
n/an/aHHS-administeredHHS-Administered Federal External Review (MAXIMUS Federal Services)
Notes

Georgia uses HHS-administered federal external review process per CMS classification (KFF 2024 listing). OCI took over Patient Rights to Independent Review Act duties from DCH on 2022-07-01 but does not publish overturn statistics.

Guam
GU
n/a
n/a
HHS-administered
n/an/aHHS-administeredHHS-Administered Federal External Review (MAXIMUS Federal Services)
Notes

U.S. territory using HHS-administered federal process. CMS does not publish jurisdiction-level case totals.

Hawaii
HI
2023
n/a
No published rate found
n/an/astate-runHawaii Insurance Division (DCCA)
Notes

Data gap on count fields: Hawaii does publish an Annual External Review Report (2023 most recent located). Underlying PDF binary not parseable in our pipeline; cite the report URL directly.

Idaho
ID
n/a
n/a
No published rate found
n/an/astate-runIdaho Department of Insurance
Notes

Data gap: Idaho DOI does not publish public external-review statistics.

Illinois
IL
2024
n/a
No published rate found
n/an/astate-runIllinois Department of Insurance (IDOI)
Notes

Data gap on count fields: IDOI Annual Report to the Governor 2024 references external-review program but tabular case counts not extracted from binary PDF in our pipeline. Hotline: 877-850-4740.

Indiana
IN
n/a
n/a
No published rate found
n/an/astate-runIndiana Department of Insurance
Notes

Data gap: IROs must file annual reports with IDOI but the Department does not publish a consolidated public external-review statistics document.

Iowa
IA
n/a
n/a
No published rate found
n/an/astate-runIowa Insurance Division
Notes

Data gap: Iowa Insurance Division publishes annual reports but does not specifically itemize external-review overturn statistics in a discoverable form.

Kentucky
KY
n/a
n/a
No published rate found
n/an/astate-runKentucky Department of Insurance
Notes

Data gap: Kentucky DOI does not publish public external-review statistics.

Louisiana
LA
n/a
n/a
No published rate found
n/an/astate-runLouisiana Department of Insurance
Notes

Data gap: LDOI does not publish public external-review overturn statistics.

Maine
ME
2023
n/a
No published rate found
n/an/astate-runMaine Bureau of Insurance (Consumer Health Care Division)
Notes

Maine's Consumer Health Care Division publishes annual external review report incorporated into Superintendent's 2023 Annual Report. Specific case counts not extracted from binary PDF in our pipeline; cite source URL directly.

Michigan
MI
2024
n/a
No published rate found
n/an/astate-runMichigan Department of Insurance and Financial Services (DIFS)
Notes

Data gap on count fields: DIFS publishes PRIRA (Patient's Right to Independent Review Act) decisions individually on its site but does not publish consolidated overturn statistics in a discoverable form. 2024 DIFS Annual Report identified.

Mississippi
MS
2024
n/a
HHS-administered
n/an/aHHS-administeredHHS-Administered Federal External Review (MAXIMUS Federal Services)
Notes

Mississippi historically classified as relying on HHS-administered federal process. Note KFF 2024 state list only flags 5 states (AL/FL/GA/TX/WI); MS may have shifted classification. Flag for re-verification.

Missouri
MO
n/a
n/a
No published rate found
n/an/astate-runMissouri Department of Commerce and Insurance
Notes

Data gap: Missouri DCI does not publish public external-review overturn statistics.

Montana
MT
n/a
n/a
No published rate found
n/an/astate-runMontana Commissioner of Securities and Insurance
Notes

Data gap: CSI Montana does not publish public external-review statistics.

Nebraska
NE
n/a
n/a
No published rate found
n/an/astate-runNebraska Department of Insurance
Notes

Data gap: Nebraska DOI does not publish public external-review statistics. Note: NE was previously HHS-administered; KFF 2024 list shows state-run, flag for verification.

Nevada
NV
n/a
n/a
No published rate found
n/an/astate-runNevada Division of Insurance
Notes

Data gap: Nevada Division of Insurance does not publish a discoverable external-review statistics report.

New Hampshire
NH
n/a
n/a
No published rate found
n/an/astate-runNew Hampshire Insurance Department
Notes

Data gap: NHID 2025 Annual Report identified but specific external-review counts not extracted.

New Jersey
NJ
n/a
n/a
No published rate found
n/an/astate-runNew Jersey Department of Banking and Insurance (DOBI) IHCAP
Notes

Data gap on count fields: DOBI's Independent Health Care Appeals Program (IHCAP) publishes periodic reports (48th IHCAP report identified) but case-level statistics not extracted from binary PDF in our pipeline. KFF 1998-era data cited Connecticut + NJ in 50-72% historic range.

New Mexico
NM
n/a
n/a
No published rate found
n/an/astate-runNew Mexico Office of Superintendent of Insurance (OSI)
Notes

Data gap: NM OSI does not publish public external-review overturn statistics.

New York
NY
2024
n/a
No published rate found
n/an/astate-runNew York Department of Financial Services (DFS)
Notes

NY DFS publishes the most extensive external-appeal database in the US (searchable: https://www.dfs.ny.gov/public-appeal/search). Aggregate 2024 counts referenced in DFS 2024 Annual Report; specific tables not extracted from binary PDF in our pipeline. Independent dashboard at https://appeal-explorer.persius.org

North Dakota
ND
n/a
n/a
No published rate found
n/an/astate-runNorth Dakota Insurance Department
Notes

Data gap: ND Insurance Department does not publish public external-review statistics.

Northern Mariana Islands
MP
n/a
n/a
HHS-administered
n/an/aHHS-administeredHHS-Administered Federal External Review (MAXIMUS Federal Services)
Notes

U.S. territory using HHS-administered federal process. CMS does not publish jurisdiction-level case totals.

Ohio
OH
2019
n/a
No published rate found
n/an/astate-runOhio Department of Insurance
Notes

Data gap on count fields: Most recent publicly posted Annual Health Claims External Review Report is 2019. Ohio law requires annual publication but current-year reports not published online; flag as significant transparency gap.

Oklahoma
OK
n/a
n/a
No published rate found
n/an/astate-runOklahoma Insurance Department
Notes

Data gap: OID does not publish public external-review statistics.

Puerto Rico
PR
n/a
n/a
No published rate found
n/an/astate-runPuerto Rico Office of the Insurance Commissioner
Notes

KFF 2024 classifies Puerto Rico as operating an NAIC-parallel state-run external-review process; OCS does not publish public overturn statistics.

Rhode Island
RI
n/a
n/a
No published rate found
n/an/astate-runRhode Island Office of the Health Insurance Commissioner (OHIC)
Notes

Data gap: OHIC does not publish a discoverable external-review statistics document.

South Dakota
SD
n/a
n/a
No published rate found
n/an/astate-runSouth Dakota Division of Insurance
Notes

Data gap: SD Division of Insurance publishes IRO process documentation but no overturn statistics.

Tennessee
TN
n/a
n/a
No published rate found
n/an/astate-runTennessee Department of Commerce and Insurance (TDCI)
Notes

Data gap: TDCI returned $17.54M to consumers via mediation in 2024 but does not break out external-review overturn statistics.

Texas
TX
n/a
n/a
No published rate found
n/an/astate-runTexas Department of Insurance (TDI)
Notes

Data gap on count fields: TDI publishes IRO decisions individually but does not publish consolidated overturn statistics. Note: KFF 2024 lists TX as HHS-administered; TDI operates state-level IRO process for workers' compensation and certifies IROs. Methodology divergence: TX IRO data structure differs materially from CA DMHC IMR; not directly comparable.

U.S. Virgin Islands
VI
n/a
n/a
HHS-administered
n/an/aHHS-administeredHHS-Administered Federal External Review (MAXIMUS Federal Services)
Notes

U.S. territory using HHS-administered federal process. CMS does not publish jurisdiction-level case totals.

Utah
UT
n/a
n/a
No published rate found
n/an/astate-runUtah Insurance Department
Notes

Data gap: Utah Insurance Department does not publish public external-review statistics.

Vermont
VT
n/a
n/a
No published rate found
n/an/astate-runVermont Department of Financial Regulation (DFR)
Notes

Data gap: Vermont DFR publishes Health Insurers Annual Reports with claims/appeals data but does not specifically itemize external-review overturn rates in a public summary.

Virginia
VA
n/a
n/a
No published rate found
n/an/astate-runVirginia Bureau of Insurance (State Corporation Commission)
Notes

Data gap: VA Bureau of Insurance does not publish a discoverable external-review statistics report.

Wisconsin
WI
2024
n/a
HHS-administered
n/an/aHHS-administeredHHS-Administered Federal External Review (MAXIMUS Federal Services) / Wisconsin OCI
Notes

Wisconsin operates partial state external-review framework but classified by KFF (2024) as relying on HHS-administered process for the full external-review pathway. WI OCI 2024 Wisconsin Insurance Report identified at https://oci.wi.gov/Documents/AboutOCI/2024_WIR.pdf

Wyoming
WY
n/a
n/a
No published rate found
n/an/astate-runWyoming Department of Insurance
Notes

Data gap: WY DOI does not publish public external-review statistics.

Reading note. Denominators are not comparable across jurisdictions. Some states count cases received; some count cases completed; some count completed-and-eligible. California and Maryland publish a complaint-process reversal rate that is broader than the strict IRO-only overturn. See the methodology document for the per-row caveats.

Explore the data

Sort it, filter it, see the spread.

The chart plots only the jurisdictions that publish a figure. The table below is every jurisdiction we surveyed. Both are the exact numbers each authority reported, with the “what this is / is not” caveats attached.

Measured reversal rate by jurisdiction (14 of 56 publish one)
0%25%50%75%100%Connecticut80.0%California72.7%Maryland66.8%North Carolina54.3%Kansas54.0%Pennsylvania48.4%Colorado44.0%Minnesota43.0%South Carolina43.0%Massachusetts40.0%Oregon38.9%Washington25.0%Arizona21.0%West Virginia17.0%

What this is: the share of external-review cases a jurisdiction reports as overturned in full or part, exactly as the jurisdiction published it. What it is not: a like-for-like ranking. Denominators differ (cases received vs. completed vs. eligible), some figures are cumulative multi-year, and a few are complaint-process rates broader than IRO-only review. Empty jurisdictions publish no figure at all.

Sortable, filterable table of external-review reversal rates by U.S. jurisdiction.
OverturnedSystem
ConnecticutCT202480.0%n/an/astate-run
CaliforniaCA202472.7%n/an/astate-run
MarylandMD202466.8%n/an/astate-run
North CarolinaNC202454.3%282153state-run
KansasKS202454.0%n/an/astate-run
PennsylvaniaPA202548.4%1,353655state-run
ColoradoCO202444.0%n/an/astate-run
MinnesotaMN202443.0%n/an/astate-run
South CarolinaSC202443.0%n/an/astate-run
MassachusettsMA202340.0%n/an/astate-run
OregonOR202538.9%278108state-run
WashingtonWA202425.0%n/an/astate-run
ArizonaAZ201421.0%n/an/astate-run
West VirginiaWV202417.0%n/an/astate-run
AlabamaAL2024n/an/an/aHHS-administered
AlaskaAKn/an/an/an/astate-run
American SamoaASn/an/an/an/aHHS-administered
ArkansasARn/an/an/an/astate-run
DelawareDEn/an/an/an/astate-run
District of ColumbiaDCn/an/an/an/astate-run
FloridaFL2024n/an/an/aHHS-administered
GeorgiaGA2024n/an/an/aHHS-administered
GuamGUn/an/an/an/aHHS-administered
HawaiiHI2023n/an/an/astate-run
IdahoIDn/an/an/an/astate-run
IllinoisIL2024n/an/an/astate-run
IndianaINn/an/an/an/astate-run
IowaIAn/an/an/an/astate-run
KentuckyKYn/an/an/an/astate-run
LouisianaLAn/an/an/an/astate-run
MaineME2023n/an/an/astate-run
MichiganMI2024n/an/an/astate-run
MississippiMS2024n/an/an/aHHS-administered
MissouriMOn/an/an/an/astate-run
MontanaMTn/an/an/an/astate-run
NebraskaNEn/an/an/an/astate-run
NevadaNVn/an/an/an/astate-run
New HampshireNHn/an/an/an/astate-run
New JerseyNJn/an/an/an/astate-run
New MexicoNMn/an/an/an/astate-run
New YorkNY2024n/an/an/astate-run
North DakotaNDn/an/an/an/astate-run
Northern Mariana IslandsMPn/an/an/an/aHHS-administered
OhioOH2019n/an/an/astate-run
OklahomaOKn/an/an/an/astate-run
Puerto RicoPRn/an/an/an/astate-run
Rhode IslandRIn/an/an/an/astate-run
South DakotaSDn/an/an/an/astate-run
TennesseeTNn/an/an/an/astate-run
TexasTXn/an/an/an/astate-run
U.S. Virgin IslandsVIn/an/an/an/aHHS-administered
UtahUTn/an/an/an/astate-run
VermontVTn/an/an/an/astate-run
VirginiaVAn/an/an/an/astate-run
WisconsinWI2024n/an/an/aHHS-administered
WyomingWYn/an/an/an/astate-run

Figures are reproduced exactly as each jurisdiction published them. Read the methodology for per-row caveats, or download the CSV.

Methodology summary

How we built it. What we did not do.

What we did

  • Surveyed all 50 state Departments of Insurance plus DC and the 5 U.S. territories.
  • Cross-checked KFF's 2024 ACA marketplace data, CMS external-appeals factsheet, and NBC News' 2025 multi-state reporting.
  • Anchored every numeric cell to a single primary source URL.
  • Flagged five categories of caveat: HHS-administered, cumulative-period, broader-than-IRO, methodology divergence, and data gap.

What we did not do

  • Invent numbers for states that do not publish them.
  • Roll up a single national average. Denominators are not comparable.
  • Split out cancer / oncology subsets. This is the general external-review universe.
  • Include Medicare Advantage IRE data, that is a separate federal regime with materially different overturn dynamics.
  • Include workers' compensation IMR data.
Reuse this dataset

Built to be cited, embedded, and corrected.

Dataset v1.0 · resource package last updated 2026-09-04. Released under CC-BY-4.0: free to redistribute and adapt with attribution.

Embed the live table + chart
<iframe
  src="https://apellica.com/external-review-index/embed"
  title="Apellica External Review Index — state reversal rates"
  width="100%" height="900" loading="lazy"
  style="border:1px solid #e2e2e2;max-width:820px"></iframe>
<p style="font:13px/1.5 system-ui,sans-serif;color:#555;max-width:820px">
  Source: <a href="https://apellica.com/external-review-index">Apellica External
  Review Index</a> (CC-BY-4.0).
</p>
Attribution line (required by the CC-BY-4.0 license)

Source: Apellica External Review Index (CC-BY-4.0). https://apellica.com/external-review-index

How to cite this dataset

Apellica (2026). The Apellica External Review Index: U.S. State External-Review Reversal Rates 2026. v1.0. Released 2026-05-19; resource package updated 2026-09-04. CC-BY-4.0. https://apellica.com/external-review-index

Researchers and journalists: link a specific figure to its stable per-state URL, e.g. apellica.com/external-review-index/west-virginia. Attribution is required by the license; a link back to apellica.com/external-review-index satisfies it.

Corrections & updates

Found an error, or a newer state report? Email editorial@apellica.com with (1) the jurisdiction, (2) the value or source you believe is correct, and (3) a public-record URL. Verified corrections are folded into the next dated resource update. Press contact: press@apellica.com.

Apellica is an independent appeal-preparation service. It is not a regulator, a law firm, a Medicare entity, or a medical provider. This asset republishes public regulatory data as a free research resource; it contains no patient-identifying information.

Got a denial? You are in the 99%.

The lottery is not just where you live. It is whether you appeal at all. A senior reviewer reads your file within one business day.